Hubei Biocause Pharmaceutical Co., Ltd.

Symbol: 000627.SZ

SHZ

2.3

CNY

Trhová cena dnes

  • -19.6629

    Pomer P/E

  • 0.1626

    Pomer PEG

  • 11.27B

    MRK Cap

  • 0.05%

    Výnos DIV

Hubei Biocause Pharmaceutical Co., Ltd. (000627-SZ) Finančné výkazy

Na grafe môžete vidieť predvolené čísla v dynamike pre Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ). Príjmy spoločnosti zobrazuje priemerná hodnota NaN M, ktorá je NaN % gowth. Priemerný hrubý zisk za celé obdobie je NaN M, čo je NaN %. Priemerný pomer hrubého zisku je NaN %. Rast čistého zisku za minuloročné výsledky spoločnosti je NaN %, ktorý sa rovná NaN % % v priemere za celú históriu spoločnosti.,

Súvaha

Keď sa ponoríme do fiškálnej trajektórie spoločnosti Hubei Biocause Pharmaceutical Co., Ltd., pozorujeme priemerný rast aktív. Je zaujímavé, že táto miera predstavuje , čo odráža maximá aj minimá spoločnosti. V porovnaní medzi štvrťrokmi sa tento údaj upraví na . Pohľad späť za minulý rok odhaľuje celkovú zmenu aktív o NaN. Hodnota akcionárov, vyjadrená celkovým vlastným imaním akcionárov, sa oceňuje na NaN v mene vykazovania. Medziročná zmena tohto aspektu je NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

balance-sheet.row.cash-and-short-term-investments

02995228391.826157.8
30248.8
15203.5
18317.5
15336.9
10953.2
61.6
58.9
124.3
152.8
74.1
72.9
95.1
306.7
111.3
73.5
26.9
16.8
55.5
73.7
247
104.9
74.6
96
104.9
113.5
13.9
13.9
13.6

balance-sheet.row.short-term-investments

01798.42082.52907.5
3391.6
2211.8
62842.7
4164.8
50767.4
418.6
0
0
0
0
0
0
16.1
3.2
1.3
0
0
0
1.4
0
0
0
0
12
0
13.5
13.5
13.5

balance-sheet.row.net-receivables

00-28453.617772.1
15069.6
10639.8
45548.8
9204.3
7697.9
83.7
140.8
188.6
339.1
391
277
295.6
231
198.2
318.7
428
407.2
455.9
280.7
296.1
28.7
8.7
8
4.1
5.6
3.4
0.2
26

balance-sheet.row.inventory

04131.91050410224.5
10716.2
3671.6
3820.5
569.4
438.5
136.1
140.4
133.9
134.4
150.2
194.2
273.9
259.2
200.4
156.1
135
128.6
125.8
129.8
90.7
70.6
75.6
66.7
16.1
30
18.4
5.3
1.4

balance-sheet.row.other-current-assets

0045535.3-3796
-4291.5
-3729.8
-17868.2
2283.9
645.2
57.7
53.8
-8.1
-98.7
-45.5
-33.6
-29.1
-26.9
0.1
-93.8
-146.6
-130.9
-169.3
0
-105.7
171.7
92.1
73.9
23.9
18.1
23.2
19
-12.8

balance-sheet.row.total-current-assets

050665.955977.650358.4
51743.1
25785
49818.6
27394.5
19734.9
339.2
394
438.7
527.6
569.9
510.5
635.5
770
510
454.5
443.3
421.7
467.9
484.2
528.1
375.9
251.1
244.7
149
167.2
58.9
38.3
28.2

balance-sheet.row.property-plant-equipment-net

01290.6844.1830.3
580.4
567.2
770.9
698.9
587.4
334.7
454.2
619.2
601.7
448.9
527
798.5
612.4
374.3
354.7
336.6
343.3
338.4
322.2
262.9
355.1
376.4
274.9
159.7
111.5
63
32.9
26.5

balance-sheet.row.goodwill

06192.56192.26192.2
6192.2
6186.3
6186.3
6186.3
6186.3
0
0
0
0
0
1.8
1.8
1.8
1.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0283.2299.3269.7
190
109.4
213.4
519.9
549.1
490.4
503.9
363.5
374.7
382.8
410.6
363.6
316.5
261.9
257.6
179.6
186.8
189.1
184.4
123.5
105
109.3
16.4
16.8
16.3
10.8
3.8
3.9

balance-sheet.row.goodwill-and-intangible-assets

06475.76491.66461.9
6382.2
6295.7
6399.7
6706.2
6735.4
490.4
503.9
363.5
374.7
382.8
412.3
365.4
318.3
263.7
257.6
179.6
186.8
189.1
184.4
123.5
105
109.3
16.4
16.8
16.3
10.8
3.8
3.9

balance-sheet.row.long-term-investments

0133897.1129743.213020.4
12217.8
12396.1
12983.8
15056.2
8280.1
742
716.8
689.8
543.4
463.3
517.5
330.1
260.4
172.5
100.1
127
127.3
94
100.6
74.4
43.9
22.5
139.1
12
0
13.5
13.5
13.5

balance-sheet.row.tax-assets

026542280.31010.3
976.2
944.2
1189.4
39.5
69.8
69.3
30.5
45.7
17.3
18.7
8.9
9.1
7.6
4.7
-2.7
-127
-127.3
-94
-2.7
0
1.8
1.9
2.3
-12
0
-13.5
-13.5
-13.5

balance-sheet.row.other-non-current-assets

0106952.593262192222.6
167502.9
159285.8
107091.6
90521.3
82469.2
433.6
9.1
0
0
0
0
17.2
10.9
-0.7
3.2
128.4
129.5
95.6
1.7
0.2
4.6
9.4
5
44.3
35.9
1.7
3.1
1.4

balance-sheet.row.total-non-current-assets

0251270232621.1213545.5
187659.6
179488.9
128435.4
113022.2
98141.8
2070.1
1714.5
1718.3
1537.1
1313.7
1465.8
1520.3
1209.6
814.6
712.9
644.6
659.6
623.1
606.2
461
510.4
519.5
437.8
220.8
163.8
75.5
39.8
31.8

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0301935.9288598.7263904
239402.6
205273.9
178254
140416.7
117876.7
2409.2
2108.5
2157
2064.7
1883.6
1976.3
2155.7
1979.5
1324.5
1167.4
1087.9
1081.3
1091
1090.4
989.1
886.3
770.7
682.5
369.8
331
134.4
78.2
60.1

balance-sheet.row.account-payables

0949206.993.5
35
156.5
83.5
106.1
82.8
74.4
112.8
208.7
84.8
62.6
34.8
37.5
45
67.9
119.6
45.7
51
25.7
26.8
18.6
51.6
29.5
40.1
19
12.5
7.5
3.1
0

balance-sheet.row.short-term-debt

018248.121189.69425.8
4583.8
6179.8
4640
7732.3
1414
303.5
428.9
484.6
327.8
253.2
142.8
274.8
192.7
279.4
231.9
252.4
251.4
284.4
249.4
134.5
154.4
96.4
54.9
7.7
14.9
8.1
3.3
6

balance-sheet.row.tax-payables

078.585.1142.5
65.4
223.8
338.4
19.2
53.3
2.1
3.7
-43.3
-48.5
-9.7
0.6
6.9
2.8
29.3
11.2
3.6
2.4
6.6
9.7
32
26.4
15.4
6.2
6.6
15.1
8.8
10.5
2.2

balance-sheet.row.long-term-debt-total

07170.86877.96203.6
2760.3
-69.4
110.5
40.5
360
42
0
0
23
123
123
225
160
30
30
0
0
0
0
0
9
14
14
58.4
56.8
24.4
2.7
5.8

Deferred Revenue Non Current

0179576.7241.8154781.7
147076.1
69.4
10.9
15.3
16
17.6
19.4
0
0
0
0
0
-160
-30
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0463347.4258.5
52
69.4
21424.5
8957.1
2072
8.3
8.8
14.5
12.6
5.9
13.1
20.5
11.8
17.6
21.7
23.7
22.7
19.3
16.8
8.2
12.8
5.3
4.9
0.8
6.4
1.5
0.8
6.9

balance-sheet.row.total-non-current-liabilities

0243840.1229010213369.4
196798.4
162486.6
125753.1
103441.9
93669.4
198.5
41.3
15.8
34.8
134.5
134.5
225
160.2
30
30
0
0
0
0
0
9
16.2
15.2
58.4
56.8
24.4
2.7
5.8

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

071.689.6111.2
69.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0268302.2253995.8226429.3
204814.7
170920.5
152239.5
113711.8
97479.2
625.5
618.8
720.7
527.4
469.5
374.2
581.3
466.8
458.5
443.7
356.7
357.4
372.2
322.4
226.1
291.8
199
189.5
176.6
130.9
82
34.3
18.8

balance-sheet.row.preferred-stock

001085.90
763.7
595.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

04940.64940.64940.6
4940.6
4940.6
4940.6
4940.6
4259.2
1353.6
1353.6
1353.6
1353.6
1353.6
1353.6
676.8
676.8
594.8
594.8
594.8
594.8
594.8
594.8
517.2
278.9
232.4
129.1
103.2
103.2
40.5
40.5
40.5

balance-sheet.row.retained-earnings

053106508.56327.4
5909.4
5829
4247.5
3142.4
1922.7
184.6
-37
-171.9
-70.8
-82.7
19
104.6
58.6
106.1
13.1
-31.5
-37.4
-41.7
6.4
27.8
73.4
59.9
36.2
12
32.9
3.4
0
0.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

00-1085.9236.6
-763.7
-595.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

010339.49962.811048.6
10284.9
10453.5
9804
11254
7619.9
201.5
132.4
214.1
214.7
105.3
172.4
736.8
726.2
113.6
99.1
94.7
93.5
92.8
92.8
143.6
175.4
215.1
312.4
77.9
64
8.5
3.3
0

balance-sheet.row.total-stockholders-equity

020590.12141222553.3
21134.9
21223.1
18992.1
19337
13801.8
1739.7
1449
1395.8
1497.5
1376.2
1545
1518.2
1461.6
814.5
707
658
650.9
645.9
694
688.7
527.7
507.4
477.7
193.2
200.1
52.4
43.9
41.3

balance-sheet.row.total-liabilities-and-stockholders-equity

0301935.9288598.7263904
239402.6
205273.9
178254
140416.7
117876.7
2409.2
2108.5
2157
2064.7
1883.6
1976.3
2155.7
1979.5
1324.5
1167.4
1087.9
1081.3
1091
1090.4
989.1
886.3
770.7
682.5
369.8
331
134.4
78.2
60.1

balance-sheet.row.minority-interest

013043.71319114921.3
13453
13130.4
7022.5
7367.8
6595.7
44
40.7
40.4
39.9
37.9
57
56.3
51.2
51.6
16.7
73.2
73
72.9
74.1
74.3
66.8
64.2
15.3
0
0
0
0
0

balance-sheet.row.total-equity

033633.834602.937474.7
34587.9
34353.5
26014.5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0135695.6131825.7116261.7
119224.9
120538.2
75826.6
61072.9
59047.4
1160.6
716.8
689.8
543.4
463.3
517.5
330.1
244.3
169.3
98.7
127
127.3
94
99.2
74.4
43.9
22.5
139.1
24
0
27
27
27

balance-sheet.row.total-debt

025418.928067.59425.8
4583.8
6179.8
4640
7732.3
1414
303.5
428.9
484.6
327.8
253.2
142.8
274.8
192.7
279.4
231.9
252.4
251.4
284.4
249.4
134.5
154.4
96.4
54.9
7.7
14.9
8.1
3.3
6

balance-sheet.row.net-debt

0-2734.71758.2-13824.5
-22273.3
-6811.9
-13677.5
-3439.9
-9539.2
241.9
370
360.3
175
179.1
69.9
179.7
-97.9
171.4
159.7
225.5
234.6
228.9
177.1
-112.5
49.6
21.7
-41.1
-85.2
-98.7
7.7
2.9
5.9

Výkaz peňažných tokov

Finančné prostredie spoločnosti Hubei Biocause Pharmaceutical Co., Ltd. zaznamenalo za posledné obdobie pozoruhodnú zmenu voľného peňažného toku, ktorý vykazuje posun NaN. Spoločnosť nedávno rozšírila svoje základné imanie vydaním NaN, čo v porovnaní s predchádzajúcim rokom znamená rozdiel NaN. Výsledkom investičnej činnosti spoločnosti bolo čisté použitie hotovosti vo výške NaN v mene vykazovania. V porovnaní s predchádzajúcim rokom ide o posun o NaN. V tom istom období spoločnosť zaznamenala NaN, NaN a NaN, ktoré sú významné pre pochopenie investičných a splátkových stratégií spoločnosti. Finančné aktivity spoločnosti viedli k čistému použitiu hotovosti vo výške NaN, pričom medziročný rozdiel predstavoval NaN. Okrem toho spoločnosť vyčlenila NaN na výplatu dividend svojim akcionárom. Zároveň uskutočnila ďalšie finančné manévre, označované ako NaN, ktoré tiež výrazne ovplyvnili jej peňažný tok v tomto období. Tieto zložky spolu vytvárajú komplexný obraz o finančnej situácii spoločnosti a strategickom prístupe k riadeniu peňažných tokov.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

0510.6880.21117.9
2918.6
2377.3
2678.3
3108.8
250.5
84.1
-100.4
13.8
-107.2
29.1
55.3
17.1
101.6
53.1
8.1
4.9
-49
7.8
46.7
40.3
35.4
30.5

cash-flows.row.depreciation-and-amortization

0147.3133.963.7
79.2
1123.9
122.9
139.3
64.8
73.5
68.8
52.4
62.9
66.5
52.3
40.5
42
35.6
37.6
35.9
34.2
37.3
28.9
28.6
25.1
13.1

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

016073.111933.530709.3
35361
-26789.8
5245.9
-6232.5
23.9
-78.9
116.7
78
51.7
149.3
-122.8
-96.1
27.3
51.8
-13.7
15
-22.3
-131.2
-41.5
-83.5
-23.6
-52.1

cash-flows.row.account-receivables

01642.4-609.1-279.5
1548.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-279.6471.1-188.3
177.6
120.5
-130.9
-302.4
1.7
-6.5
0.5
15.8
12.3
79.7
-14.7
-58.7
-44.4
-21
-6.4
-1.8
4
-37.2
-20.1
4.9
8.9
-29

cash-flows.row.account-payables

0-1642.4609.1279.5
-1548.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

016352.611462.530897.6
35183.5
-26910.3
5376.7
-5930.1
22.2
-72.4
116.2
62.2
39.5
69.6
-108.1
-37.3
71.6
72.9
-7.3
16.8
-26.3
-94
-21.4
-88.4
-32.5
-23.1

cash-flows.row.other-non-cash-items

0-9206.7-8775.1-10469.8
-9759.2
38269.9
-7615.5
642
-385.9
-200
45.4
-50.4
59.5
-20.2
-5.3
24.9
-52.3
-12.4
16.7
0.3
11.2
16.5
3.2
10
10
3.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-135.1-287.1-308.4
-717.1
-274.7
-778.9
-3678.3
-40.8
-185.5
-143.8
-128.5
-149.4
-93.1
-261.7
-361.7
-64.8
-130.1
-24.5
-25.5
-21.5
-146.1
-31.5
-6.3
-99.2
-10.8

cash-flows.row.acquisitions-net

0171.8-3440.5
258.8
334.3
1.4
3.5
3.2
103.1
162.9
131
44.3
0
263.4
361.8
65.9
130.1
0
28.3
21.8
146.9
0.2
10.7
0
10.8

cash-flows.row.purchases-of-investments

0-97626.8-109755-71494.6
-123082.8
-77372.7
-139091.6
-115403.5
-6.2
-230
-146.7
-60
-40
-120.1
-40
-189
-60
-55.6
-0.8
-39
-165.8
-184.7
-24.8
-20.2
0
-31.5

cash-flows.row.sales-maturities-of-investments

084126.194717.767783.5
88942.6
68035
129051.5
104526.6
182.1
464.4
89
130
170
0
17.8
92.7
43.2
26.7
0
15.6
175.7
129.6
1.1
12.2
29.9
12

cash-flows.row.other-investing-activites

0-1996.2-62.2-222.2
-445.9
102.8
-47.8
17138.3
7.1
5.3
-143.8
-128.5
-149.4
207.6
-261.7
-361.7
-64.8
-130.1
0
-25.5
-21.5
-146.1
62
-6.3
0.5
-10.8

cash-flows.row.net-cash-used-for-investing-activites

0-15615-15384.8-7682.2
-35044.3
-9175.3
-10865.4
2586.6
145.4
157.2
-182.4
-56
-124.4
-5.6
-282.2
-458
-80.4
-159
-25.3
-46.2
-11.3
-200.6
7
-9.9
-68.8
-30.3

cash-flows.row.debt-repayment

0-11763.8-7701.9-854.1
-102.8
-288
-790
-447.5
-464.9
-573.5
-463.3
-294.8
-223.3
-594.8
-279.7
-413.2
-231.9
-255.8
-240.6
-235.4
-329.9
-345.9
-178.9
-59.8
-67.9
-17.2

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-699.4-381.3-634
-242.1
-311.6
-148
-117.1
-24.5
-30.6
-30.4
-28.7
-21.6
-37.3
-20
-52.4
-17.8
-12.3
-14.3
-15.5
-15
-16.1
-22.7
-15.1
-6.2
-58.7

cash-flows.row.other-financing-activites

02354115703.91660.6
1470.2
1940.4
11597.1
11190.3
407
515.3
484.6
364.4
303.7
390.8
406.8
1119.6
247.4
344.2
241.6
202.4
364.9
457.5
299.4
119.6
74.8
114.5

cash-flows.row.net-cash-used-provided-by-financing-activities

011077.87620.6172.6
1125.3
1340.8
10659.2
10625.7
-82.4
-88.8
-9.1
40.9
58.8
-241.3
107.2
654.1
-2.3
76.2
-13.3
-48.6
20
95.5
97.8
44.7
0.6
38.6

cash-flows.row.effect-of-forex-changes-on-cash

072-15.2-33.9
-1.4
1.6
-2.1
3.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.1
0

cash-flows.row.net-change-in-cash

03059-3606.913877.6
-5320.8
7148.4
223.2
10873.7
16.2
-52.8
-61.1
78.7
1.3
-22.2
-195.5
182.6
35.8
45.3
10
-38.7
-16.8
-174.7
142.2
30.2
-21.4
3.1

cash-flows.row.cash-at-end-of-period

026309.323250.326857.1
12979.5
18300.4
11152
10928.8
55.1
38.9
91.8
152.8
74.1
72.9
95.1
290.6
108
72.2
26.9
16.8
55.5
72.3
247
104.9
74.6
96

cash-flows.row.cash-at-beginning-of-period

023250.326857.112979.5
18300.4
11152
10928.8
55.1
38.9
91.8
152.8
74.1
72.9
95.1
290.6
108
72.2
26.9
16.8
55.5
72.3
247
104.9
74.6
96
92.9

cash-flows.row.operating-cash-flow

07524.24172.621421.1
28599.6
14981.3
431.6
-2342.3
-46.7
-121.3
130.5
93.8
66.9
224.6
-20.5
-13.5
118.6
128.2
48.7
56.1
-25.9
-69.6
37.3
-4.6
46.9
-5.2

cash-flows.row.capital-expenditure

0-135.1-287.1-308.4
-717.1
-274.7
-778.9
-3678.3
-40.8
-185.5
-143.8
-128.5
-149.4
-93.1
-261.7
-361.7
-64.8
-130.1
-24.5
-25.5
-21.5
-146.1
-31.5
-6.3
-99.2
-10.8

cash-flows.row.free-cash-flow

07389.13885.521112.7
27882.5
14706.7
-347.4
-6020.6
-87.5
-306.8
-13.3
-34.7
-82.4
131.5
-282.2
-375.2
53.8
-1.9
24.1
30.5
-47.4
-215.8
5.8
-10.9
-52.3
-16

Riadok výkazu ziskov a strát

Príjmy Hubei Biocause Pharmaceutical Co., Ltd. zaznamenali v porovnaní s predchádzajúcim obdobím zmenu o NaN%. Hrubý zisk spoločnosti 000627.SZ sa vykazuje vo výške NaN. Prevádzkové náklady spoločnosti sú NaN, ktoré vykazujú zmenu o NaN% oproti minulému roku. Náklady na odpisy sú NaN, čo predstavuje NaN% zmenu oproti poslednému účtovnému obdobiu. Prevádzkové náklady sa vykazujú vo výške NaN, ktorá vykazuje NaN% medziročnú zmenu. Výdavky na predaj a marketing predstavujú NaN, čo je NaN% zmena oproti predchádzajúcemu roku. EBITDA na základe posledných čísel je NaN, čo predstavuje NaN% medziročný nárast. Prevádzkový zisk je NaN, ktorý vykazuje NaN% zmenu v porovnaní s predchádzajúcim rokom. Zmena čistého príjmu je NaN%. Čistý príjem za posledný rok bol NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

049725.849615.749583.2
43576
50192.1
30950.8
53405.6
16995.5
541.1
806.4
968
779.7
1133.8
1261.2
964.6
909.3
835.8
560.8
518.7
463
422.7
348.6
356
322
255.9
192.3
237.5
143.7
83.3

income-statement-row.row.cost-of-revenue

09829.68458.67311.6
3225.1
8172.6
2866.9
4036.6
1788.5
518
829.8
977.5
753.2
1111.8
1185.8
866.2
835.1
726.1
475.6
451.1
410.6
380.8
268.7
261.2
240.2
193
155.3
176.4
98.2
53.9

income-statement-row.row.gross-profit

039896.241157.142271.6
40350.8
42019.5
28083.9
49368.9
15207
23.1
-23.4
-9.6
26.5
22
75.3
98.4
74.2
109.7
85.1
67.7
52.5
41.8
79.9
94.9
81.8
62.8
37
61.2
45.6
29.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-48509.69825.59896.8
36146.5
30062.1
-24280.3
-23688.3
-6190.4
3.1
8.3
13.2
1.5
0.3
9.8
6
5
6
10.3
4.7
9.5
1.5
2.6
8.3
7.3
20.6
11.9
5.6
6.6
2

income-statement-row.row.operating-expenses

0-48509.610159.510437.9
36774.7
30668.5
2614.7
26761
6911.4
79.6
70.9
73.6
63.9
80.2
67.9
52.8
59
55.4
45.9
49.3
50.8
83.4
57
45
36.6
36.2
13
10
10.3
6.8

income-statement-row.row.cost-and-expenses

0-51566.718618.117749.5
39999.8
38841.1
5481.6
30797.6
8699.9
597.6
900.7
1051.1
817.1
1192
1253.7
919
894.1
781.4
521.5
500.4
461.3
464.2
325.6
306.1
276.7
229.2
168.3
186.3
108.5
60.7

income-statement-row.row.interest-income

0000
0
0
0
16.1
0
2.3
2.6
1.5
2.2
3.7
1.8
2.7
14.7
4.2
3.9
0.5
3.2
0.2
1.7
5.2
1.5
0
0
0
0
0

income-statement-row.row.interest-expense

0031200.6423.8
170.5
101.3
0
0
0
24.5
30.6
30.4
28.7
21.6
25.8
23.3
32.1
21
16.1
14.3
13.9
15.5
10.7
8.5
8.3
-0.4
-0.6
0.3
1.4
0.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-1868-30964.1-32573.9
-2432.1
-8419.3
-18306.3
-4428.3
-1585.5
390.9
203.2
-45.4
52.4
-58.5
23.6
13.6
-7.9
58.1
13.2
-14.4
0.5
-9.5
-9.1
-0.2
-3.1
6.1
12.8
6.6
10.1
6.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-48509.69825.59896.8
36146.5
30062.1
-24280.3
-23688.3
-6190.4
3.1
8.3
13.2
1.5
0.3
9.8
6
5
6
10.3
4.7
9.5
1.5
2.6
8.3
7.3
20.6
11.9
5.6
6.6
2

income-statement-row.row.total-operating-expenses

0-1868-30964.1-32573.9
-2432.1
-8419.3
-18306.3
-4428.3
-1585.5
390.9
203.2
-45.4
52.4
-58.5
23.6
13.6
-7.9
58.1
13.2
-14.4
0.5
-9.5
-9.1
-0.2
-3.1
6.1
12.8
6.6
10.1
6.2

income-statement-row.row.interest-expense

0031200.6423.8
170.5
101.3
0
0
0
24.5
30.6
30.4
28.7
21.6
25.8
23.3
32.1
21
16.1
14.3
13.9
15.5
10.7
8.5
8.3
-0.4
-0.6
0.3
1.4
0.3

income-statement-row.row.depreciation-and-amortization

01840.9147.3133.9
63.7
79.2
1123.9
122.9
139.3
64.8
73.5
68.8
52.4
62.9
66.5
52.3
40.5
42
35.6
37.6
35.9
34.2
37.3
28.9
28.6
25.1
13.1
-11.9
-13.4
-8.3

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

01216.331188.832917
3881.5
12052.8
2653.6
2727.4
3424.8
332.2
101.1
-141.1
14.9
-113.7
22.2
53.2
2.3
106.4
53.1
8.2
-1.7
-45.1
15.8
57.5
48.3
41.8
30.7
63.1
48.6
30.8

income-statement-row.row.income-before-tax

0-1868224.8343.1
1449.5
3633.4
2636.4
2724.3
3432.6
334.4
109
-128.6
15
-116.7
31.1
59.2
7.3
112.4
57.9
8.4
5
-47.3
16.2
57.7
48.9
47.6
39.7
63.3
50.3
30.8

income-statement-row.row.income-tax-expense

0-1216.3-285.8-537.1
331.6
714.9
259.1
46
323.7
83.9
24.8
-28.1
1.2
-9.5
2
3.9
-0.1
20.5
4.8
0.3
0.1
1.7
8.3
11
8.5
12.2
9.2
8.5
13.4
8

income-statement-row.row.net-income

0-651.8510.6880.2
1117.9
2918.6
1326.5
1326.2
1778.7
247.3
83.8
-101
11.8
-101.7
28.3
55.8
-23.8
89.7
48.4
7.1
5.1
-48.1
5.3
37.2
34.2
31.3
30.2
54.8
36.9
22.8

Často kladené otázky

Čo je Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) celkové aktíva?

Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) celkové aktíva sú 301935930342.000.

Aký je ročný obrat podniku?

Ročné príjmy sú N/A.

Aké je ziskové rozpätie podniku?

Zisková marža firmy je 0.698.

Aký je voľný peňažný tok podniku?

Voľný peňažný tok je -2.454.

Aká je čistá zisková marža podniku?

Čistá zisková marža je -0.007.

Aké sú celkové výnosy podniku?

Celkové príjmy sú 0.006.

Aká je Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) čistý zisk (čistý príjem)?

Čistý zisk (čistý príjem) je -651784800.000.

Aký je celkový dlh firmy?

Celkový dlh je 25418877126.000.

Aké je číslo prevádzkových nákladov?

Prevádzkové výdavky sú -48509569700.000.

Aký je údaj o hotovosti spoločnosti?

Peňažné prostriedky podniku sú 0.000.